Don't miss our holiday offer - up to 50% OFF!
Tirzepatide: The Dual-Agonist Peptide in Metabolic Research
A dual GIP/GLP-1 agonist central to metabolic research.
Tirzepatide is a dual-agonist peptide that has become a major reference point in metabolic and glucose-regulation research.
What it is
Tirzepatide is studied as an agonist at both the GIP and GLP-1 receptors — two incretin pathways involved in metabolic signaling. This dual mechanism is central to research interest.
Why it’s studied
Research models use tirzepatide to investigate how combined GIP/GLP-1 activation influences glucose handling and energy metabolism relative to single-pathway compounds.
Quality matters
As a compound used quantitatively in research, documented purity and identity are essential — per-batch COAs and third-party HPLC testing.
Research-grade Tirzepatide from Prestige Sciences — ≥99% purity by HPLC, a Certificate of Analysis on every batch, shipped across Colombia with insured delivery.
For laboratory and research use only. Not for human or veterinary consumption. This article is educational and describes published research; it is not medical advice and makes no product claims.